Skip to main content
VEXT Science, Inc. logo

VEXT Science, Inc. — Investor Relations & Filings

Ticker · VEXT ISIN · CA9255401064 LEI · 549300ZLMMU2KEEORR23 CSE Manufacturing
Open in API
Filings indexed 390 across all filing types
Latest filing 2026-05-21 Earnings Release
Country CA Canada
Listing CSE VEXT

About VEXT Science, Inc.

https://www.vextscience.com

VEXT Science, Inc. is a vertically integrated cannabis operator specializing in cultivation, manufacturing, and retail distribution. The company's core operations are centered in Arizona and Ohio, where it owns and manages state-of-the-art facilities and dispensaries. VEXT manufactures and distributes a portfolio of cannabis products, prominently featuring the Vapen™ brand, which includes leading THC concentrates, edibles, and distillate cartridges. VEXT leverages integrated agricultural technology and a focus on cutting-edge science to ensure product quality and consistency across its distribution network, which also includes strategic partnerships in additional U.S. states. The company has maintained profitable operations since 2016.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Earnings Release Classification · 95% confidence The document is a press release announcing the company’s Q1 2026 financial results, including revenue, EBITDA metrics, management commentary, and details on the upcoming earnings conference call. It provides high-level quarterly performance highlights rather than the full interim financial statements or MD&A. This matches the definition of an Earnings Release. Q1 2026
2026-05-21 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a ‘Venture Issuer Basic Certificate’ under Form 52-109FV2, signed by the CEO certifying the interim financial report and interim MD&A. It is purely an officer’s certification/attestation of interim filings (no substantive financial data is included), which per the Certification Rule should be classified as a regulatory filing. Therefore, the appropriate category is RNS.
2026-05-21 English
Interim MD&A - English.pdf
Management Reports Classification · 98% confidence The document is titled “Management’s Discussion and Analysis for the period ended March 31, 2026” and consists of the MD&A narrative explaining quarterly financial results, business trends, and outlook. It is not the full interim financial statements alone but the management’s commentary, fitting the Management Reports category.
2026-05-21 English
News release - English.pdf
Regulatory Filings Classification · 85% confidence The document is a corporate press release announcing the execution of an investor relations services agreement with Zuanic & Associates. It does not contain financial results, shareholder votes, capital changes, board changes, filings of an audited or annual report, legal proceedings, or M&A activity, nor does it serve as the text of a conference call or investor presentation. It is a general corporate announcement best placed in the fallback Regulatory Filings category.
2026-05-15 English
News release - English.pdf
Report Publication Announcement Classification · 85% confidence The document is a press release announcing the date and conference call details for the forthcoming Q1 2026 financial results, without containing any actual financial data or highlights. It does not include the report itself but merely advises when it will be released. Under the “menu vs meal” rule, this is an announcement of the report publication rather than a full quarterly report or earnings release.
2026-05-14 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings
2026-04-29 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.